The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Adma Biologics Inc’s stock clocked out at $21.83, up 0.05% from its previous closing price of $21.82. In other words, the price has increased by $0.05 from its previous closing price. On the day, 1.94 million shares were traded. ADMA stock price reached its highest trading level at $22.1899 during the session, while it also had its lowest trading level at $21.53.
Ratios:
To gain a deeper understanding of ADMA’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 59.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 65.03. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Tade Brad L. sold 15,000 shares for $21.15 per share. The transaction valued at 317,250 led to the insider holds 199,433 shares of the business.
Grossman Adam S sold 48,967 shares of ADMA for $1,033,204 on Nov 22 ’24. The President and CEO now owns 1,989,007 shares after completing the transaction at $21.10 per share. On Nov 22 ’24, another insider, Grossman Adam S, who serves as the Director and Officer of the company, bought 48,967 shares for $21.30 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 5160393728 and an Enterprise Value of 5185076224. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 79.01, and their Forward P/E ratio for the next fiscal year is 30.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.95. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.49 while its Price-to-Book (P/B) ratio in mrq is 22.25. Its current Enterprise Value per Revenue stands at 13.545 whereas that against EBITDA is 41.186.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $3.60. The 50-Day Moving Average of the stock is 14.69%, while the 200-Day Moving Average is calculated to be 74.63%.
Shares Statistics:
It appears that ADMA traded 5.08M shares on average per day over the past three months and 2612950 shares per day over the past ten days. A total of 236.39M shares are outstanding, with a floating share count of 228.45M. Insiders hold about 3.36% of the company’s shares, while institutions hold 88.31% stake in the company. Shares short for ADMA as of 1731628800 were 14239500 with a Short Ratio of 2.80, compared to 1728950400 on 16073315. Therefore, it implies a Short% of Shares Outstanding of 14239500 and a Short% of Float of 6.2.
